机译:抗IL-1β抗体和GAD65 DNA疫苗的联合疗法可以逆转RIP-GP小鼠模型中的近期发作的糖尿病
Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology,La Jolla, CA;
Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology,La Jolla, CA;
Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology,La Jolla, CA;
Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology,La Jolla, CA;
Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology,La Jolla, CA;
Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology,La Jolla, CA;
Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology,La Jolla, CA;
Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology,La Jolla, CA;
Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology,La Jolla, CA;
Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology,La Jolla, CA;
机译:抗CD3 /抗CXCL10抗体联合疗法在两种小鼠模型中诱导1型糖尿病的持久缓解。
机译:GAD65 T细胞库中的遗传诱导变异决定了抗CD3 / GAD65联合疗法在新发1型糖尿病中的疗效。
机译:IL-15超激动剂复合物ALT-803和肿瘤靶向单克隆抗体的联合治疗可促进同基因小鼠黑素瘤模型的直接抗肿瘤活性和保护性疫苗作用
机译:光动力疗法在小鼠模型中刺激抗肿瘤免疫反应:调节性T细胞,抗肿瘤抗体的作用以及对脑转移瘤的免疫攻击
机译:通过联合疗法逆转NOD小鼠中明显的I型糖尿病
机译:抗IL-1β抗体和GAD65 DNA疫苗的联合治疗可以逆转RIP-GP小鼠模型中的近期发作的糖尿病
机译:抗CD3 /抗CXCL10抗体组合治疗在两种小鼠模型中诱导1型糖尿病的持续缓解